Results 51 to 60 of about 1,940,460 (362)

Vaccine-induced immune thrombotic thrombocytopenia

open access: yesBlood, 2023
Visual ...
D. Cines, A. Greinacher
semanticscholar   +1 more source

Primary immune thrombocytopenia in children

open access: yesPediatria Polska, 2021
Primary immune thrombocytopenia (ITP) is usually a benign and self-limiting disease in children. Due to the complex pathogenesis involving different immunological processes, its course may be unpredictable.
Agnieszka Książek, Tomasz Szczepański
doaj   +1 more source

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

open access: yesNew England Journal of Medicine, 2021
The coronavirus disease 2019 (Covid-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stimulated the development of highly effective vaccines that were produced wi...
D. Cines, J. Bussel
semanticscholar   +1 more source

Neonatal Immune Thrombocytopenia [PDF]

open access: yesMedical Journal Armed Forces India, 2004
Neonatal immune thrombocytopenia, a consequence of transplacental transfer of antiplatelet antibodies can result in serious bleeding with disastrous consequences in the otherwise healthy newborn.Over 2 years at a service hospital, 5 mothers with chronic autoimmune thrombocytopenia and one with maternal alloimmunisation delivered, which comprised the ...
P. Arora, Uma Raju
openaire   +3 more sources

COVID‐19‐associated immune thrombocytopenia

open access: yesBritish Journal of Haematology, 2020
Thrombocytopenia is a risk factor for increased morbidity and mortality in patients with the new severe acute respiratory syndrome corona virus, SARS-CoV-2 infection (COVID-19 infection).1 Thrombocytopenia in COVID-19 patients may be caused by ...
G. Bomhof   +6 more
semanticscholar   +1 more source

Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia

open access: yesBlood, 2021
New treatment options are required for patients with refractory immune thrombocytopenia (ITP), a disease in which immune tolerance has been lost due to reduced regulatory T-cell (Treg) activity.
P. Han   +15 more
semanticscholar   +1 more source

Role of thrombopoietin stimulating agents(Eltrombopag and Romiplostim) in immune thrombocytopenia secondary to SLE

open access: yesIatreia, 2021
Introduction: Immune thrombocytopenia is a frequent hematologic manifestation in systemic lupus erythematosus (SLE). Corticosteroids are the first line of treatment for moderate to severe thrombocytopenia in this disease, in conjunction with ...
Toro Vélez, Esteban   +2 more
doaj   +1 more source

Disseminated tuberculosis with severe immune thrombocytopenia

open access: yesRespiratory Medicine Case Reports, 2019
Immune thrombocytopenia is an autoimmune condition with increased platelet destruction. Immune thrombocytopenic purpura is an uncommon and rare manifestation of tuberculosis.
Malla Rama Krishna   +2 more
doaj   +1 more source

Cross-reactivity between piperacillin–tazobactam and cefoperazone–sulbactam in drug-induced immune thrombocytopenia

open access: yesJournal of International Medical Research, 2023
Beta-lactam antibiotics commonly cause immune thrombocytopenia. Cross-reactivity in patients with drug-induced immune thrombocytopenia has rarely been reported. In this study, we describe the case of a 79-year-old man who developed thrombocytopenia after
Xiaoyan He   +5 more
doaj   +1 more source

A distinct plasmablast and naïve B-cell phenotype in primary immune thrombocytopenia

open access: yesHaematologica, 2016
Primary immune thrombocytopenia is an autoimmune disorder in which platelet destruction is a consequence of both B- and T-cell dysregulation. Flow cytometry was used to further characterize the B- and T-cell compartments in a cross-sectional cohort of 26
Shaun M. Flint   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy